Neprilysin

Neprilysin

Neprilysin 詳細

Molecule Name
Neprilysin
分子の別称
MME,CALLA,CD10,DKFZp686O16152,MGC126681,MGC126707,NEP,SFE,Neprilysin
Drug Development Progress
治験薬の数8
市販薬剤の数3
研究&開発段階Approved
ターゲットの別称
EC:3.4.24.11,EC 3.4.24,Atriopeptidase,NEP,SFE,Membrane Metallo-Endopeptidase (Neutral Endopeptidase, Enkephalinase, CALLA, CD10),Membrane Metallo-Endopeptidase Variant 1,Membrane Metallo-Endopeptidase Variant 2,Neprilysin-390,Neprilysin-411,CD10 Antigen,EC 3.4.24.11,CMT2T,SCA43,EPN,MME,Enkephalinase,CALLA,Neutral endopeptidase,Common acute lymphocytic leukemia antigen,Neprilysin,CD10,Membrane Metalloendopeptidase,Neutral Endopeptidase 24.11,Skin fibroblast elastase
バックグランド
Cluster of differentiation 10 (CD10) is also known as membrane metallo-endopeptidase, neutral endopeptidase (NEP), Neprilysin, and common acute lymphoblastic leukemia antigen (CALLA), is a 90-110-kDa type II transmembrane glycoprotein normally expressed by a variety of tissues, including epithelial cells of the prostate, kidney, intestine, endometrium, adrenal glands, and lung. This zinc-dependent metalloprotease enzyme cleaves peptide bonds on the amino side of hydrophobic residues and inactivates a variety of physiologically active secreted peptides. CD20 is thought to be the rate-limiting degrading enzyme of amyloid β peptide (Aβ) whose abnormal misfolding and aggregation in neural tissue has been implicated in the development of Alzheimer's disease (AD). CD10 is also identified as the common acute lymphoblastic leukemia antigen (CALLA) present on leukemic cells of pre-B phenotype, and thus serves as the most important biomarker in the diagnosis of human acute lymphocytic leukemia (ALL).

Neprilysin 製品リスト

Species
  • Human(3)
Tag
  • Fc Tag(1)
  • His Tag(1)
  • Tag Free(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(3)
Grade
  • RUO(3)
Low Endotoxin
  • No(3)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
Neprilysin
Human Neprilysin / MME / CD10 Protein, Tag Free (active enzyme)
Human
HEK293
SDS-PAGE
Enzyme

$410.00

50ug
Neprilysin
Human Neprilysin / MME / CD10 Protein, His Tag, low endotoxin (active enzyme, MALS verified)
Human
HEK293
MALSSDS-PAGE
Enzyme

$368.00

100ug
Neprilysin
Human Neprilysin / MME / CD10 Protein, Fc Tag
Human
HEK293
SDS-PAGE

$290.00

50ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
DexecadotrilPhase 3 ClinicalBioprojet Pharma
Gastrointestinal Diseases
詳細
Sacubitril/Valsartan (Chong Kun Dang Pharmaceutical)CKD-202APhase 3 ClinicalChong Kun Dang Pharmaceutical Corp
Essential Hypertension
詳細
QR-12000QR-12000Phase 3 ClinicalWuhan Createrna Science and Technology Co Ltd
Essential Hypertension; Hypertension
詳細
Debio-0827PL-37; Debio-0827Phase 2 ClinicalPharmaleads
Pain
詳細
SacubitrilAHU-377Phase 2 ClinicalNovartis Pharma Ag
Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Diabetes Mellitus; Essential Hypertension; Heart Failure; Hypertension; Insulin Resistance; Metabolic Diseases
詳細
Anti-CD10 CAR T-cell therapy (Zhujiang Hospital/Nanfang Hospital)Phase 1 ClinicalSouthern Medical University Zhujing Hospital
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
詳細
Sacubitril Valsartan Sodium Extended-Relesae Tablets(Taizhou Overseas Pharma)Phase 1 ClinicalTaizhou Overseas Pharmaceuticals Co Ltd
Heart Failure
詳細
Sacubitril/Allisartan Isoproxil/Amlodipine BesylatePhase 1 ClinicalShenzhen Salubris Pharmaceuticals Co Ltd
Essential Hypertension
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Sacubitril/Allisartan IsoproxilAHU-377/EXP3174; S-086ApprovedShenzhen Salubris Pharmaceuticals Co Ltd信超妥Mainland ChinaEssential HypertensionShenzhen Salubris Pharmaceuticals Co Ltd2025-05-20
Essential Hypertension; Heart Failure; Hypertension
詳細
Sacubitril/Valsartan Sodium HydrateLCZ-696; LCZ-696AApprovedNovartis Pharma AgENTRESTO SPRINKLE, Enresuto, Enrest, Entresto, Neparvis, 诺欣妥, 科畅欣United StatesHeart FailureNovartis Pharmaceuticals Corp2015-07-07
Breast Neoplasms; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Erectile Dysfunction; Essential Hypertension; Heart Defects, Congenital; Heart Diseases; Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Hepatic Insufficiency; Hypertension; Lymphoma; Myocardial Infarction; Obesity; Peripheral Arterial Disease; Postmyocardial Infarction Syndrome; Renal Insufficiency; Renal Insufficiency, Chronic; Ventricular Dysfunction, Left
詳細
RacecadotrilTiorfan; HidrasecApprovedBioprojet PharmaFranceDiarrheaBioprojet Pharma1993-03-23
Diarrhea; Diarrhea, Infantile; Sepsis
詳細
Customer Reviews